DENTSPLY SIRONA Inc. $XRAY Shares Bought by Private Management Group Inc.

Private Management Group Inc. boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 18.9% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 2,936,998 shares of the medical instruments supplier’s stock after acquiring an additional 466,272 shares during the period. Private Management Group Inc.’s holdings in DENTSPLY SIRONA were worth $26,022,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. BlackRock Inc. bought a new stake in shares of DENTSPLY SIRONA in the second quarter valued at approximately $283,405,000. Southpoint Capital Advisors LP purchased a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at approximately $116,000,000. Edmond DE Rothschild Holding S.A. bought a new position in DENTSPLY SIRONA in the 2nd quarter worth approximately $47,780,000. Dimensional Fund Advisors LP boosted its holdings in DENTSPLY SIRONA by 31.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,559,388 shares of the medical instruments supplier’s stock worth $41,284,000 after buying an additional 850,261 shares during the period. Finally, Paradigm Capital Management Inc. NY bought a new position in DENTSPLY SIRONA in the 2nd quarter worth approximately $39,775,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY opened at $9.54 on Tuesday. The firm has a market capitalization of $1.90 billion, a price-to-earnings ratio of 7.45, a P/E/G ratio of 1.37 and a beta of 0.87. DENTSPLY SIRONA Inc. has a 52-week low of $8.14 and a 52-week high of $14.76. The stock has a fifty day moving average of $9.57 and a 200 day moving average of $11.26. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last announced its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.02). The business had revenue of $836.00 million during the quarter, compared to the consensus estimate of $861.68 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%. DENTSPLY SIRONA’s revenue was down 7.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.37 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. On average, research analysts expect that DENTSPLY SIRONA Inc. will post 1.33 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently commented on XRAY shares. Piper Sandler cut their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Friday, October 9th. Barrington Research decreased their price objective on DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, October 26th. Mizuho dropped their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Thursday, October 22nd. JPMorgan Chase & Co. cut their target price on DENTSPLY SIRONA from $12.00 to $10.00 and set a “neutral” rating for the company in a research note on Friday. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DENTSPLY SIRONA in a report on Friday, October 30th. Three analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $12.42.

View Our Latest Analysis on DENTSPLY SIRONA

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care.

The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.

DENTSPLY SIRONA was formed in 2016 through the merger of DENTSPLY International and Sirona Dental Systems, bringing together businesses with long histories in dental products and equipment.

Read More

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.